Home  |   Equities  |   Indexes  |   Commodities  |   Forex  |   News  |   Analysis  |   Top/Flop  |   Screening  |   Forums
May 26, 2012 12:10 am US/Eastern
Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  PuriCore plc    PURI   GB00B3XBCR18

Real time Streaming quotes -

PURICORE PLC

 (PURI)

 
Delayed Quote. Delayed London Stock Exchange - 05/25 11:35:14 am
52 GBp   --.--%
04/26DJUK SMALLCAP ROUNDUP: Asos Expects Percentage Of Revenue From Overseas To R..
03/29 PURICORE PLC: Appointment of New Chairman and Board Changes
02/01 PURICORE PLC: BBSRC grants an Industrial Partner award to The University o..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsForum 
 

PuriCore plc : PuriCore Raises $3.5 Million

01/03/2012 | 03:11pm
PuriCore plc ("PuriCore" or the "Company" or the "Group") PuriCore Raises $3.5 Million MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 3 January 2012 - PuriCore (LSE: PURI), the water- based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, announces that it closed on a new $3.5 million debt facility with Republic Bank on 29 December 2011. The debt will be utilized to finance the working capital requirements associated with Sterilox Fresh and FloraFresh System installations in H1 2012. The facility is structured as a promissory note with an imputed interest rate of 4%. Enquiries:

FTI Consulting Susan Quigley Ben Brewerton

+44 (0) 20 7831 3113

About PuriCore

PuriCoreplc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. PuriCore's solutions are proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.

1

 
React to this article
Latest news on PURICORE PLC
04/26DJAsos Expects Percentage Of Revenue From Overseas To Rise
03/29 Appointment of New Chairman and Board Changes
02/01 BBSRC grants an Industrial Partner award to The University of Oxford to Study Pu..
02/01 Appointment of New Independent Non-Executive Director
01/17 PuriCore's Aqualox System Confirmed for Used by EPA
01/03 PuriCore Raises $3.5 Million
2011 PuriCore Receives Two Major Contracts
2011 PuriCore Extends Repayment Date of Convertible Loan Notes
2011 ActiVita Agriculture System Confirmed for Use by US EPA
2011 PuriCore Launches Vashe Wound Therapy for Instillation Applications
Advertisement
Chart
Duration : Period :
PuriCore plc Technical Analysis Chart | PURI | GB00B3XBCR18 | 4-Traders
Income Statement Evolution
PuriCore plc : Income Statement Evolution
More Financials
Advertisement